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Abstract 30 
Experiments investigated neuroanatomically localized changes in de novo DNA 31 
methyltransferase expression in the female Siberian hamster (Phodopus sungorus). The 32 
objectives were to identify the neuroendocrine substrates that exhibit rhythmic Dnmt3a and 33 
Dnmt3b expression across the oestrous cycle and examine the role of ovarian steroids. 34 
Hypothalamic Dnmt3a expression was observed to significantly increase during the transition 35 
from proestrous to oestrous. A single bolus injection of diethylstilbestrol (DES) and 36 
progesterone was sufficient to increase Dnmt3a cell numbers and Dnmt3b immunoreactive 37 
intensity in the suprachiasmatic nucleus (SCN). In vitro analyses using an embryonic rodent 38 
cell line revealed that DES was sufficient to induce Dnmt3b expression. Upregulating DNA 39 
methylation in vitro reduced expression of vasoactive intestinal polypeptide, Vip, and the 40 
circadian clock gene, Bmal1. Together, these data indicate that ovarian steroids drive de novo 41 
DNA methyltransferase expression in the mammalian suprachiasmatic nucleus and increased 42 
methylation may regulate genes involved in the circadian timing of oestrous: Vip and Bmal1. 43 
Overall, epigenetically mediated neuroendocrine reproductive events may reflect an 44 
evolutionarily ancient process involved in the timing of female fertility. 45 
 46 
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Introduction 51 
Gonadotropin-releasing hormone (GnRH) is an evolutionarily conserved neuropeptide 52 
that is necessary for sexual reproduction (1). In mammals, the oestrous cycle is characterized 53 
by gonadotropin pulses that exhibit low frequency during the luteal phase but increase 54 
significantly during the follicular phase (2). On the evening of proestrous, there is a 55 
circadian-dependent surge in gonadotropin secretion; after which GnRH pulse frequency 56 
slows considerably (3). A fundamental feature of the circadian timing of the proestrous surge 57 
is a neural network between the suprachiasmatic nucleus (SCN) and the anterior 58 
hypothalamus/preoptic area (AH/POA) (4). Multiple SCN neurons provide tissue-level 59 
control for timing the luteinizing hormone (LH) surge. Two neuropeptides highly expressed 60 
in the SCN that are consistently implicated in driving GnRH release include vasoactive 61 
intestinal polypeptide (Vip) (5) and arginine vasopressin (Avp) (6). 62 
There is now strong evidence that epigenetic modifications affect the timing of puberty 63 
(7,8), but whether epigenetic modifications are involved in the neuroendocrine control of the 64 
oestrous cycle remains uncharacterized. DNA methylation is one type of epigenetic 65 
modification present in diverse taxa and is involved in the control of gene regulation (9); 66 
normally associated with transcriptional silencing. DNA methyltransferases (Dnmt) are a 67 
family of enzymes that catalyse the transfer of methyl-groups to the genome template (10) to 68 
maintain the pattern of methylation (imprinting control) or to modify the methylation pattern 69 
de novo. It has recently emerged that de novo DNA methylation is reversible and can exhibit 70 
clear oscillations in post-mitotic cells (14). In mammals de novo methylation activity is 71 
performed primarily by two Dnmt3 enzymes, Dnmt3a and Dnmt3b, encoded by separate 72 
genes (11, 12). Dnmt3a and Dnmt3b can induce both CpG and non-CpG methylation and 73 
exhibit similar kinetic activity (11). Both Dnmt3a and Dnmt3b express multiple distinct 74 
isoforms with some that lack DNA methylation activity (i.e. Dnmt3b3, see 11). Dnmt3a and 75 
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Dnmt3b show highly conserved expression patterns across mammalian evolution with high 76 
expression in brain and reproductive tissues (e.g. testes and uterus) (12,13). It has recently 77 
emerged that de novo DNA methylation is reversible and can exhibit clear oscillations in 78 
post-mitotic cells (14). In uterine tissue, expression of Dnmt3a and Dnmt3b in endometrial 79 
cells (15-17) appears to be involved with decidualization (18). The prevailing hypothesis is 80 
that Dnmt3a-driven changes in uterine function is a critical step for synchronising peripheral 81 
reproductive function in mammals (15,16). In the brain, de novo DNA methyltransferase 82 
expression has been localized in several hypothalamic nuclei, including diencephalic centres 83 
critically involved in reproduction, such as the SCN (19,20), the ependymal layer along the 84 
3rd ventricle (3rdV) (21) and the AH/POA (22). 85 
Siberian hamsters are an important animal model for studying the neuroendocrine control 86 
of reproductive physiology (23,24). Prior work in hamsters demonstrated that hypothalamic 87 
global DNA methylation was elevated in long-day breeding compared to short-day 88 
reproductively regressed hamsters (21). Increased global DNA methylation in the 89 
hypothalamus correlated with significantly higher Dnmt1 and Dnmt3a expression (25). 90 
Seasonal variation in hypothalamic Dnmt3a expression has also been associated with 91 
photoperiod induced changes in the timing of seasonal physiology and migratory behaviour 92 
in the red-headed bunting (Emberiza bruniceps) (26). Seasonal changes in hypothalamic 93 
Dnmt3a/b expression also correlates with increased methylation in the proximal promoter of 94 
a thyroid hormone deiodinase gene (Dio3) (21) and is negatively correlated with Dio3 95 
expression (21,26). These data indicate that rhythmic epigenetic modifications, such as 96 
neuroendocrine variation in DNA methylation, is associated with the long-term programming 97 
of seasonal reproduction (14).  98 
The objectives of the current study were to examine anatomically localised changes and 99 
ovarian-steroid dependent regulation of de novo DNA methyltransferase expression in the 100 
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female hypothalamus. Using Siberian hamsters, we investigated Dnmt3a and Dnmt3b mRNA 101 
during proestrous and oestrous to understand if expression changes prior to -or after the LH 102 
surge. Then, we ovariectomised females and administered either a single bolus injection of 103 
oil or an ovarian steroid mixture of the highly potent estrogen agonist diesthylstilbestrol 104 
(DES) and progesterone (P) compared to vehicle control to identify hormone-dependent 105 
effects on Dnmt3a and Dnmt3b protein expression in the hamster hypothalamus. Next, we 106 
cultured a rodent embryonic cell line derived from mouse hypothalamus (mHypoE N36/1) to 107 
explore the ability of DES to regulate the expression of Dnmt3a and Dnmt3b in vitro. We 108 
also tested the impact of DES administration on the expression of neuropeptides implicated in 109 
timing the gonadotropin surge during proestrous, including Vip, vasopressin (Avp) and 110 
kisspeptin (Kiss1). To identify a functional role of DNA methylation for timing reproductive 111 
physiology, we then used the mHypoE N36/1 cells to investigate whether epigenetic 112 
modifying drugs influence the expression of Vip, Avp and Kiss1. Furthermore, we examined 113 
the impact of increased DNA methylation on circadian clock genes: brain and muscle ARNT-114 
like 1 (Bmal1), period 1 (Per1) and clock (Clock). Our findings suggest that ovarian steroids 115 
control the expression of de novo DNA methyltransferases in distinct regions of the 116 
hypothalamus and increased DNA methylation may influence multiple genomic targets 117 
involved in the neuroendocrine regulation of the oestrous cycle. 118 
 119 
Methods 120 
Siberian hamster colony and ethical approvals 121 
These studies used female hamsters derived from a colony maintained at the 122 
University of Aberdeen. Hamsters were housed in polypropylene cages illuminated for 123 
16h/day (lights-on 800h). Harlan food and tap water were provided ad libitum and each cage 124 
was provided cotton-nesting material. All procedures were approved by the University of 125 
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Aberdeen Animal Welfare and Ethics Committee and Home Office (PPL 70/7017). All 126 
procedures were in accordance with the Arrive Guidelines for ethical research involving 127 
animals.  128 
 129 
Study 1 – Characterization of Dnmt3a and Dnmt3b expression during the hamster proestrous 130 
and oestrous stages 131 
Animals: 132 
Adult female (3-8 months, n=19) were taken from the University of Aberdeen 133 
breeding colony and group housed. Animals were kept in LD (16L:8D) and samples were 134 
collected between 1500h-1700h to capture the proestrous surge in prolactin (15, 27). The age 135 
range of female hamsters was equivalent across both experimental groups. Hamsters were 136 
then sacrificed using cervical dislocation and brains were collected and frozen on powdered 137 
dry ice before being transferred to -70°C. The reproductive state of the hamsters was 138 
published previously (15). We investigated RNA expression in hypothalami from proestrous 139 
(n=11) and oestrous (n=8) hamsters.  140 
 141 
Anatomical localization and dissection of the Siberian hamster anterior hypothalamus 142 
Brains were placed ventral side facing upward into a cold mouse brain matrix (Alto 143 
matrix; CellPoint Scientific). The Allen Mouse atlas was used to determine the anatomical 144 
localization of an anterior tissue punch that included the SCN, anteroventral-periventricular 145 
(AvPv) and POA, and a posterior punch that comprised the arcuate nucleus (Arc) and 146 
dorsalmedial hypothalamus (DMH). The posterior extent of the optic chiasm provided a 147 
reliable anatomical landmark to separate the anterior-posterior hypothalamic divide. A 148 
second coronal section was performed 1mm in the anterior direction (AH) and a 2mm coronal 149 
section in the posterior direction (PH). Tissue sections were then placed on a cold microscope 150 
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slide, the lateral and dorsal extent of the hypothalamus was identified, and cuts conducted to 151 
isolate the respective hypothalamic regions (Figure S1). 152 
 153 
RNA extraction, cDNA synthesis and quantitative PCR (qPCR) assay 154 
AH and PH hypothalamic tissue punches were homogenized in Trizol (ThermoFisher 155 
Scientific) and RNA extracted as per manufacturer’s guidelines. RNA concentration and the 156 
260/280 ratio were measured by NanoDrop (ThermoFisher Scientific). cDNA synthesis was 157 
carried out using First Strand cDNA synthesis kit (Invitrogen). To measure mRNA 158 
expression, cDNA was assayed using qPCR run on a BioRad CFX96. For each well the 159 
qPCR mix consisted of 5µl cDNA template, 10µl SYBR green (PrecisionPLUS qPCR Master 160 
Mix with SYBR green) 0.5µl (300nM) forward primer, 0.5µl (300nM) reverse primer and 161 
4µl RNase-free H2O to make up to 20µl. Primers were all ordered from Invitrogen, 162 
sequences for Gnrh, Rfrp3, Kiss1, Dnmt1, Dnmt3a, and Dnmt3b were optimized and 163 
published previously (21, 28) as well and the primer sequences for the reference genes 164 
glyceraldehyde 3-phosphate dehydrogenase (Gapdh) and hypoxanthine 165 
phosphoribosyltransferase 1 (Hprt) (15) (Table S1). Melt curve analyses were carried out to 166 
ensure specificity for each reaction. PCR Miner (29) was used to determine reaction 167 
efficiencies (E) and quantification cycle (Cq). According to MIQE guidelines, samples with 168 
efficiency values below 0.8 and above 1.2 were excluded from analyses (30). Fold expression 169 
of each target gene was measured in relation to the geometric mean of the Cq for two 170 
reference genes (Gapdh and Hprt) and calculated using 2-(ΔΔCq). The geometric average of 171 
the reference genes was stably expression across groups [CT x̅±SEM Est (15.4±0.2) and Pro 172 
(15.5±0.1)]. 173 
 174 
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Study 2: Assessment of ovarian steroids on Dnmt3a and Dnmt3b expression in the female 175 
hamster hypothalamus. 176 
Animals: 177 
Adult female hamsters (n=18) were ovariectomised and maintained in LD (16L:8D) for 178 
8 weeks to allow circulating ovarian hormones to clear from the circulation. In brief, 179 
ovariectomies were conducted while hamsters were under deep anaesthesia (5% isofluorane 180 
gas). The ovaries were externalized via bilateral incisions to the dorsum (lateral to the spine, 181 
caudal to the ribcage). The ovary was localized at the distal end of the uterine horn and 182 
ligated with sterile sutures (4–0, nonabsorbable monofilament nylon). The ovary was then 183 
excised and the procedure was repeated for the second ovary. The abdominal wall and skin 184 
were closed separately with sterile sutures. Hamsters recovered under analgesia and had ad 185 
libitum access to enriched food (sunflower seeds additional standard chow) and water before 186 
being transferred back to individual cages. 8 weeks following surgery a reduction in body 187 
mass of 7.5g (± 0.9g SEM) on average was observed and a reliable indicator of reduced 188 
ovarian steroids (31) and were previously reported (see 15). Hamsters were then randomly 189 
allocated into two experimental groups, one group to receive vehicle control (i.e. vegetable 190 
oil) and the other to receive an ovarian steroid injection. Diethylstilbestrol (DES, Sigma-191 
Aldrich) is a highly potent estrogen agonist (E2) with full activity at both the estrogen 192 
receptor-α and -β and was administered in conjunction with progesterone (P4, Sigma-193 
Aldrich). DES and P4 (denoted as E2P4) were dissolved in sterile vegetable oil (Oil) to a final 194 
dose of 50µg E2 and 5mg P4 per ml vegetable oil. These steroid concentrations were taken 195 
from previous work in female hamsters (32). Control hamsters (n=7) were injected with 196 
100µl oil and treatment hamsters (n=11) were injected with 100µl E2P4 cocktail (5µg E2 and 197 
500µg P4) at 1700h. Female hamster were killed by cervical dislocation either 12- or 24-198 
hours post-injection and the brain were rapidly extracted and frozen in dry ice. 199 
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 200 
Anatomical localization of Dnmt3a and Dnmt3b expression in the female hypothalami 201 
Brains were then transferred to -70°C until tissue section. Brains were coronally 202 
sectioned at 30µm thickness on a cryostat (Leica 3050 series) and mounted onto poly-L-203 
lysine/gelatine coated slides. Sections were taken from the anterior commissure through to 204 
the caudal aspect of the 3rdV, the full dorso-ventral extension of the hippocampal pyramidal 205 
layer was used as an anatomical marker for hypothalamic localization. Coronal sections were 206 
grouped into sets (each set consisted of every 8th section) spanning the entire extent of the 207 
hypothalamus. By sectioning in this manner, we were able to encompass the rostrally located 208 
POA, SCN, 3rdV and the caudally located Arc. Tissue sectioned slides were stored at -70°C 209 
until histological assays. 210 
 211 
Immunohistochemistry 212 
Immunohistochemistry (IHC) was carried out on slide mounted coronal brain 213 
sections. The IHC protocol started with a 10-minute fixation step in ice cold 4% 214 
paraformaldehyde followed by three washes in 0.1M phosphate buffered saline (PBS) for 215 
5mins each. Antigen retrieval was carried out using 10mM sodium citrate pH 6.0 (Sigma-216 
Aldrich) heated to 95°C for 20mins then after three washes in PBS, slides were incubated in 217 
3% H2O2 (Fisher Scientific) for 30mins at room temperature. Serum blocking was carried out 218 
using a species appropriate serum (either goat or horse serum, Vector labs) at 5% in PBS for 219 
1hr at room temperature. Slides were again washed using PBSt (0.1M PBS + 0.1% Triton-X 220 
(Sigma-Aldrich)) before being incubated with primary antibody diluted in 5% serum at the 221 
optimised concentration (see Table S2) at 4°C for 48hrs. After 3 PBSt washes, sections were 222 
incubated with a biotinylated secondary antibody appropriate for the species that the primary 223 
antibody was raised in for 1hr at room temperature. In this study, the Tyramide Signal 224 
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Amplification (TSA) Biotin system was used to amplify the signal (Perkin-Elmer, 225 
NEL700A001) (33). Briefly, once slides had been incubated with the respective biotinylated 226 
secondary antibody, they were washed in PBSt and then incubated with streptavidin-227 
horseradish peroxidase conjugate for 30mins at room temperature. Slides were then washed 228 
in PBSt 3 times for 5mins, and subsequently incubated with tyramide solution for 7mins at 229 
room temperature. Slides are washed with PBSt before incubation with avidin-conjugated 230 
fluorescein (A-2001, Vector Labs) for 1hr in a darkened room. Slides were then washed in 231 
H2O for 5mins, then cover slipped with DAPI (H-1200, Vector Labs).  232 
The human peptide used to generate the Dnmt3a antibody (catalogue no. 3598; Cell 233 
Signalling Technologies, UK) shares 100% sequence homology with the hamster Dnmt3a 234 
sequence, whereas an epitope-tagged recombinant mouse Dnmt3b protein was used to 235 
generate the Dnmt3b antibody (52A1018; Novus Biologicals, UK) which shares 94% 236 
sequence homology to the characterised hamster sequence. Moreover, the antibody has been 237 
shown to exhibit cross species reactivity with sheep, rat and humans. We included multiple 238 
negative controls in our IHC protocol, including omitting primary antibody, omitting 239 
secondary antibody, or omitting TSA amplification to test for non-specific signal generation. 240 
In all cases, negligible immunoreactive signal was generated. Pre-adsorption controls were 241 
conducted for Dnmt3a using a Dnmt3a blocking peptide (3227BP-50 Cambridge Bioscience). 242 
Pre-adsorption controls used 1/500 primary antibody and either 1/100, 1/250 or 1/500 243 
blocking peptide concentrations for 3 hours before incubation with hamster tissue. All 244 
sections with blocking peptide had the Dnmt3a immunoreactive signal eliminated. 245 
 246 
Mapping and analyses of hypothalamic Dnmt3a and Dnmt3b immunoreactivity 247 
Images were captured using Axiovert 200M (Zeiss) inverted fluorescent microscope 248 
with the Axiovison (version 4.7) software and Hammamatsu camera. Image analysis was 249 
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carried out using ImageJ software (http://imagej.nih.gov/ij/) with the Fiji bioimaging plugin 250 
(34). Photomicrograph images were collected and used to measure immunoreactive Dnmt3a 251 
(ir-Dnmt3a) and Dnmt3b (ir-Dnmt3b) cell numbers and signal intensity. Overall, ir-Dnmt3a 252 
had a diffuse distribution in the hypothalamus with higher expression levels in the SCN and 253 
Arc. The Allen mouse atlas was used as a guide to determine the borders of the SCN, Arc and 254 
POA. The ventral and medial boundaries of the SCN and Arc were determined by the base of 255 
the hypothalamus and 3rdV, respectively. The expression of ir-Dnmt3a and ir-Dnmt3b cells in 256 
the SCN and Arc were within the dorsal and lateral boundaries outlined in the Allen mouse 257 
atlas. ir-Dnmt3b stain was localised to the ependymal layer of the 3rdV and SCN. Sections 258 
were approximately 240µm apart as recommended by West (35) for stereological counting of 259 
cells. Positively stained cells were counted using the Cell Counter plug-in integrated in the 260 
Fiji package where only the leading edge of positively stained cells were counted. Images 261 
were converted to 8-bit greyscale, then each cell was circled using the circle selection tool on 262 
Fiji and the mean greyscale measured. For each section 3, background measurements 263 
(adjacent brain region without positive cells) were taken to determine non-specific 264 
background fluorescence. The background was then subtracted from fluorescence intensity of 265 
each cell to allow for normalised signal intensities to be compared across images. 266 
Immunoreactive positive cell counts and signal intensity was measured for ir-Dnmt3a in the 267 
SCN and Arc, and ir-Dnmt3b in the SCN and 3rdV.  268 
 269 
Study 3 - in vitro analyses of DES and hyper- and hypo-DNA methylation on neuropeptides, 270 
circadian clock genes and de novo DNA methyltransferase expression. 271 
Cell culture 272 
The mHypoE N36/1 neuronal cell line, derived from an embryonic mouse 273 
hypothalamus (36) was used to examine the impact of hyper-methylation and Dnmt inhibition 274 
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in conjunction with hormonal regulation of mRNA levels. The mHypoE N36/1 neuronal line 275 
was selected as these cells provide an optimal in vitro model to complement the hypothalamic 276 
oestrous analyses conducted in Study 1. Furthermore, as de novo DNA methyltransferase 277 
enzymes are expressed across multiple hypothalamic nuclei (19-22); these cells provide a 278 
model to identify the effect of DES and hyper- and hypo-DNA methylation agents on select 279 
neuroendocrine targets. Cells were grown in a humidified incubator at 37°C in 5% CO2 in 280 
Dulbeccos Modified Eagle Media (DMEM - high glucose; 4,500mg/L glucose, L-glutamine 281 
and sodium bicarbonate (D5796, Sigma-aldrich), supplemented with fetal bovine serum 282 
(FBS, 10%, ATCC), penicillin (10units/ml), and streptomycin (10µg/ml) (Pen/Strep 100x, 283 
ThermoFisher) in T75 flasks (FisherScientific). Cells grown to 80% confluency before 284 
passage with trypsin/EDTA (ThermoFisher) then split and reseeded into a clean T75 flask. 285 
mHypoE N36/1 cells were used for a maximum of 25 total passages after which fresh cells 286 
were revived from frozen stocks. For experiments, cells were trypsinised and resuspended in 287 
growth media to quantify cell density and viability using trypan blue and a haemocytometer. 288 
Cells were seeded at a density of 5x105 cells/well in growth media in 24-well plates 289 
(Corning) and allowed to adhere and grow for 24 hr in a humidified incubator.  290 
The treatment groups were divided across 4 experiments. In the hypermethylation 291 
experiment, cells were exposed to 3mM 3-aminobenzamide (3AB, Sigma-Aldrich) or vehicle 292 
control (DMSO). 3AB is a well-characterized drug that induces hyper-methylation via the 293 
inhibition of poly(ADP-ribosyl)ation (37) and has previously been shown to increase 294 
hypothalamic DNA methylation in hamsters (21). In the Dnmt inhibition experiment, cells 295 
were incubated with 100µM zebularine (ZEB, Selleckchem) or control (saline). We examined 296 
Kiss1, Avp and Vip expression in response to 3AB and ZEB as these neuropeptides are 297 
involved in the control of reproductive physiology and previously shown to be regulated by 298 
DNA methylation (38-40). To test the influence of ovarian steroids, cells were incubated with 299 
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1nM diethylstilbesterol (DES, Sigma-Aldrich) or vehicle control (ethanol). Finally, a 300 
hormone positive control experiment was run using cells exposed to 10mM 301 
dihydrotestosterone (DHT, Sigma-Aldrich), or ethanol (vehicle control). Prior to hormone 302 
treatments, cells were subjected to serum starvation for 24hr using serum-free growth media, 303 
followed by a saline wash. Serum-free media was used for DES and DHT experiments to 304 
minimize any confounding effects of serum steroid hormones (41). Cells used in the 3AB, 305 
ZEB and DTH experiments were incubated with 1ml of respective treatment media for either 306 
9hr or 24hrs in a humidified chamber with 5% CO2 at 37°C. Cells treated with DES were 307 
incubated with 1ml of respective media for only 24hrs.  All samples were lysed in vitro using 308 
RLT buffer supplemented with 1% v/v β-mercaptoethanol from the Qiagen RNeasy Mini kit 309 
and stored at -70°C. 310 
 311 
RNA extraction and cDNA synthesis 312 
RNA from cells was isolated using the RNeasy Mini Kit (Qiagen). According to the 313 
manufacturer’s protocol using 33ul nuclease-free H2) to elute the purified RNA from the spin 314 
column. The concentration of eluted RNA was determined using a NanoDrop (ThermoFisher) 315 
and the RNA was then stored at -70°C until further processing. cDNA was synthesized using 316 
oligo dT primers (Precision nanoScript2 Reverse Transcription kit, Primer Design) according 317 
to the manufacturer’s directions.  318 
 319 
qPCR assay for Dnmt3a, Dnmt3b and reproductive neuropeptides 320 
qPCRs were run on a BioRad CFX96 Real time PCR machine in a 20µl reaction. 321 
Primers were supplied by Invitrogen and the primer sequences are provided in Table S3. Both 322 
Dnmt3a and Dnmt3b express multiple isoforms in many human, mouse and rat tissues. The 323 
hamster Dnmt3a and Dnmt3b primers are not designed to distinguish between the various 324 
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Dnmt3a and Dnmt3b isoforms described in rodents (i.e. mice or rats). Therefore, the qPCRs 325 
for Dnmt3a and Dnmt3b provide an overall assessment of transcript levels. All samples were 326 
run in duplicate in a 96-well plate format under the following cycling conditions; i) initial 327 
denaturing at 95°C for 5min, then 39 cycles of ii) 95°C for 10secs, iii) 30 secs at annealing 328 
temperature dependent on gene of interest, then iv) an extension step of 72°C for 30secs. For 329 
each qPCR assay no-template H2O controls (NTC) were included. Melt curve were examined 330 
to confirm specificity of the amplification reaction. PCR Miner (25) was used to determine 331 
reaction efficiencies (E) and quantification cycle (Cq). According to MIQE guidelines, 332 
samples with efficiency values below 0.8 and above 1.2 were excluded from analyses (30). 333 
Fold expression of each target gene was measured in relation to the geometric mean of the Cq 334 
for two reference genes (gapdh and βactin) and calculated using 2-(ΔΔCq). The reference 335 
gene was stable across treatment groups and drug treatments [CT x̅±SEM Control (19.6±0.1) 336 
and 3AB (19.5±0.1); [CT x̅±SEM Control (22.1±0.1) and DES (22.1±0.1)]; and [CT x̅±SEM 337 
Control (17.9±0.2) and ZEB (18.2±0.7)]. 338 
 339 
Statistical analyses 340 
For Study 1, a two-tailed t-test was conducted to determine whether the expression of 341 
hypothalamic Dnmt1, Dnmt3a and Dnmt3b was different between proestrous and oestrous 342 
females. Since Dnmt3a expression increased during oestrous, we conducted one-tailed t-tests 343 
to examine statistical significance in the E2P4 driven changes in the number of ir-Dnmt3a 344 
and ir-Dnmt3b cells and signal intensity. Moreover, one-tailed t-tests were also conducted on 345 
DES-driven mRNA expression in Study 3. Data were log-transformed in the event a violation 346 
of normality was observed. Statistical analyses were performed using SigmaPlot 13.0 and 347 
significance was determined at p≤0.05. 348 
 349 
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Results 350 
Hypothalamic Dnmt3a expression varies between proestrous and oestrous stages 351 
The precision of the tissue punches targeting the AH and PH was confirmed by Gnrh, Kiss1 352 
and Rfrp3 mRNA expression. Gnrh was only identified in the AH, Kiss1 was localized to the 353 
AH (i.e. AvPv/POA) and PH (i.e. Arc), and Rfrp3 was expressed at higher levels in the PH 354 
(i.e. DMH) (Fig S1C-E). Dnmt3a expression was significantly higher in the AH tissue-355 
punches during oestrous (P<0.05), but neither Dnmt1 (P>0.20) nor Dnmt3b (P>0.34) differed 356 
between these stages (Fig. 1). Dnmt1, Dnmt3a and Dnmt3b expression in the PH did not vary 357 
across the oestrous stages (P>0.05 for all comparisons). Dnmt3a expression was significantly 358 
higher in the AH, whereas Dnmt1 and Dnmt3b expression was significantly greater in the PH 359 
(data not shown). 360 
 361 
Ovarian steroids stimulate ir-Dnmt3a and ir-Dnmt3b in hypothalamic nuclei. 362 
 To determine the impact of ovarian steroids, adult hamsters were ovariectomized 363 
(OVX) and after 8 weeks were treated with E2P4 or vehicle control (oil), and ir-Dnmt3a/b 364 
immunoreactivity was examined histologically either 12h or 24h later. There was no 365 
significant effect of time on ir-Dnmt3a nor ir-Dnmt3b expression in any nuclei examined 366 
(P>0.18 for all comparisons). Therefore, we combined the data from both treatment groups. 367 
E2P4 was found to significantly increase the number of ir-Dnmt3a cells in the SCN (Fig. 2A-368 
B; P=0.05), without influencing their fluorescence intensity (Fig. 3A; P>0.05). In the Arc, ir-369 
Dnmt3a cell numbers were not affected by E2P4 (Fig. 2C-D; P>0.05), nor was their 370 
fluorescence intensity (Fig. 3B; P>0.05). Furthermore, E2P4 treatment failed to alter the 371 
number of ir-Dnmt3b cells or signal intensity in the 3rdV (Fig. 2E-F, Fig. 3D, respectively; 372 
P>0.49), but caused an increase in ir-Dnmt3b signal intensity in the SCN (Fig. 3C; P<0.05). 373 
Collectively, these data indicate that ovarian steroids markedly upregulate ir-Dnmt3a and ir-374 
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Dnmt3b expression specifically in the SCN. When compared to the oestrous study data, these 375 
results indicate that de novo DNA methyltransferase expression in anterior hypothalamic 376 
tissues including the SCN changes over the course of the female ovarian cycle; increased 377 
Dnmt3a expression coincides with, and is likely driven by, elevated ovarian steroid secretion. 378 
 379 
The potent estrogen analogue DES upregulates Dnmt3b expression in vitro. 380 
In order to begin to elucidate the molecular mechanisms by which ovarian hormones 381 
affect DNA methyltransferase activity in the HPG axis, we sought to develop a tractable in 382 
vitro model. To accomplish this, we used a well-characterised cell model, the embryonic 383 
mouse hypothalamic cell line, mHypoE N36/1 (36) to test whether DES would influence 384 
Dnmt3a and Dnmt3b expression and alter the expression of reproductive neuropeptides. 385 
Following incubation with DES, Kiss1 (P=0.01) and Vip (P<0.05; Fig. 4A) were significantly 386 
downregulated in mHypoE N36/1 cells, whereas there was no effect on Avp expression 387 
(P>0.14). Dnmt3b expression was significantly upregulated in DES treated cells (P<0.05; Fig. 388 
4B), but DES failed to alter Dnmt1 (P>0.19) or Dnmt3a (P>0.36) expression. Collectively, 389 
these results indicate that DES signalling via estrogen receptor upregulates Dnmt3b 390 
expression, without significantly affecting Dnmt1 or Dnmt3a expression, pointing to a degree 391 
of specificity in the effects of ovarian hormone secretion on de novo DNA methyltransferase 392 
induction. 393 
This assay was also used to examine whether Dnmt3a/b expression can be induced in 394 
response to the non-aromatizable androgen, dihydrotestosterone (DHT), which would offer 395 
insights into whether, in vivo, effects of DES on Dnmt3a and Dnmt3b can be mediated via 396 
androgen receptors. DHT failed to induce Dnmt1, 3a or 3b expression as compared to vehicle 397 
treated controls (Fig. 4C; P>0.10, all comparisons), indicating that, in this paradigm, 398 
androgens are not sufficient to upregulate Dnmt expression, and may indicate that, in vivo, 399 
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estrogen signalling may be the essential pathway by which gonadal hormones activate 400 
hypothalamic Dnmt expression. 401 
 402 
Functional role of DNA methylation on neuropeptide and circadian clock genes 403 
In order to identify potential targets of increased hypothalamic DNA methylation, we 404 
used two epigenetic-modifying drugs to either inhibit Dnmt enzymes with ZEB or hyper-405 
methylate DNA using 3AB. Treatments did not affect transcript expression across 9- and 24-406 
hr sampling points (P>0.28); therefore we collapsed the data to simplify the presentation of 407 
the results. To eliminate any potential effects of time on clock gene expression; qPCR was 408 
conducted using cells treated with 3AB for 24hrs. We identified 2 genes expressed in the 409 
SCN that were significantly reduced after exposure to 3AB, Vip (Fig 5A; P<0.05) and Bmal1 410 
(Fig 5B; P<0.05). The 3AB-induced hypermethylation appears to be specific as no 411 
differences in expression other reproductive neuropeptides gene (i.e. Kiss1, Avp) (Fig. 5A; 412 
P>0.16) or other circadian clock genes (i.e. Per1, Clock) (Fig. 5B; P>0.27) were observed. 413 
However, ZEB treatment reduced DNA methyltransferase but did not significantly alter Vip, 414 
Kiss1, or Avp expression (Fig. 5C; P>0.28). The lack of an effect may be due to the relatively 415 
short exposure of the cells to ZEB (i.e. <24hrs). 416 
 417 
Discussion 418 
While the impact of epigenetic modifications has been implicated in timing fertility in 419 
peripheral tissues (15-17), a role in the hypothalamus has not been investigated. This study 420 
examined the distribution of Dnmt3a and Dnmt3b across the hamster oestrous cycle and 421 
identified that ovarian steroids stimulate ir-Dnmt3a and ir-Dnmt3b expression in the SCN. 422 
During proestrus, AH (i.e. SCN) Dnmt3a expression is significantly reduced; this effect was 423 
anatomically specific, as no effect was observed in the PH, which is also sensitive to ovarian 424 
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steroid feedback. Together these data reveal a novel neuroendocrine mechanism in which 425 
epigenetic modifications driven by DNA methylation in the SCN control fertility timing in 426 
mammals. We propose that DNA methylation in the SCN provides transient inhibition on 427 
critical genes (i.e. Vip, Bmal1) that in turn, promotes cyclic changes in fertility and female 428 
sexual behaviour which constitute the oestrous cycle.  429 
These data indicate that DNA methylation may regulate SCN gene transcription as 430 
females transition from proestrous to the oestrous stage. Vip is highly expressed in the SCN 431 
and is critical for the synchronization and maintenance of molecular timekeeping (42). VIP 432 
immunoreactive neurons in the SCN also project directly onto GnRH neurons, with greater 433 
abundance after puberty (43). Male and female Vipr2-/- mice exhibit reduced fertility, and 434 
females exhibit irregular oestrous cycles (44), consistent with a model in which Vip, localized 435 
in the core circadian nuclei, functions as an integral part of the molecular machinery, 436 
regulating the neuroendocrine output of GnRH neurons. Here, we extend this model to 437 
indicate that Vip expression is significantly reduced by DES, and this may be mediated by the 438 
increased expression of Dnmt3a/3b driven DNA methylation. DES was sufficient to stimulate 439 
the expression of Dnmt3b mRNA; whereas DES and progesterone was required to drive 440 
Dnmt3a protein expression. Given the observation that Dnmt3a and Dnmt3b have dissociable 441 
effects on the genome (45), it is likely that ovarian steroids exerted independent effects on 442 
DNA methylation by selectively recruiting different Dnmt3a/b enzymes throughout the 443 
oestrous cycle. Furthermore, as the levels of estrogen receptor-α and -β expression are very 444 
low in the SCN (46), it is likely that ovarian steroids act in other hypothalamic nuclei (e.g. 445 
Arc, 47) and indirectly regulate de novo DNA methyltransferase expression in the SCN. 446 
Further examination of how estrogen and progesterone signalling regulate SCN dnmt3a and 447 
dnmt3b expression is warranted. 448 
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The daily control of female reproductive physiology requires kisspeptin-dependent 449 
regulation of GnRH release (2,5, 48). Avp-expressing cells in the SCN project to Kiss1 450 
neurons in the anteroventral periventricular and periventricular preoptic nuclei (AvPv/PeN) 451 
and may provide SCN-dependent circadian timing of oestrous (6). 3AB hypermethylation of 452 
mHypoE N36/1 cells did not affect Avp nor Kiss1 expression. These findings suggest that de 453 
novo DNA methylation may not be involved in the hamster SCN Avp to AvPv/PeN 454 
kisspeptin to GnRH neuroendocrine pathway. However, further research using in vivo 455 
approaches are required to determine whether DNA methylation regulates either Avp or 456 
kisspeptin signalling across the oestrous cycle. 457 
One pathway through which this novel effect may be mediated is via the circadian 458 
clock gene bmal1, which is a core component of the circadian clock, and is also a target for 459 
Dnmt3a (49). In vitro hyper-methylation via 3AB reduced Bmal1 expression within 24 hrs 460 
and thus indicates a functional role of DNA methylation induced changes in circadian clock 461 
gene transcription. The lack of an effect on other circadian clock genes (i.e. Per1) is likely 462 
due to the single 24hr sampling period. The assessment of circadian clock gene expression 463 
over several days is necessary in order to determine the downstream effect of increased DNA 464 
methylation on the Bmal1 expression. Daily DNA methylation oscillations in the Bmal1 465 
promoter likely exerts a critical role on the oestrous cycle by maintaining the functional 466 
integrity of the circadian transcriptional-translational feedback loop, which regulates the 467 
timing of the luteinizing hormone surge during proestrous. The present data here add to a 468 
growing body of work which indicates that, beyond its well-characterised role in 469 
embryogenesis and gametogenesis, rhythmic de novo methylation may be widespread in the 470 
adult brain. 471 
Rhythmic changes in de novo DNA methyltransferase enzymes across seasonal time 472 
scales have been reported in the hypothalamus (21,25,27), gonads (15), liver (50) and 473 
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leukocytes (51). The evidence indicates that Dnmt3a and Dnmt3b expression are regulated by 474 
a combination of environmental and endogenous signals (52). The present study reveals 475 
anatomically localized effects of ovarian steroids on Dnmt3a and Dnmt3b expression and 476 
indicates that rhythmic DNA methylation might be a novel component for the timing of 477 
female fertility. The availability of the Siberian hamster genome will facilitate the dissection 478 
of localized rhythmic DNA methylation across neuroendocrine and peripheral reproductive 479 
tissues (53).  480 
 481 
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Figure Legends 633 
 634 
Figure 1 – Oestrous plasticity in DNA methyltransferase mRNA expression in the anterior 635 
hypothalamus. The fold change in Dnmt3a mRNA in the anterior hypothalamus 636 
had significantly higher expression during oestrous (EST) compared to proestrous 637 
(PRO) hamsters. Neither Dnmt1 nor Dnmt3b were observed to be significantly 638 
different between PRO and EST stages. Asterisks indicate statistical significance 639 
by * P<0.05. Numbers in the bar graph denote sample size. 640 
 641 
Figure 2 – Ovarian steroids stimulate Dnmt3a in the suprachiasmatic nucleus. A single bolus 642 
injection of an estrogen analogue diethylstilbestrol (DES) and progesterone 643 
(denoted as E2P4) was found to have anatomically localized effects on Dnmt3a and 644 
Dnmt3b expression in the hypothalamus. Ovariectomized hamsters that received 645 
E2P4 significantly increased the number of Dnmt3a cells in the suprachiasmatic 646 
nucleus (SCN) compared to oil treated controls (OVX) (A). Representative 647 
photomicrographs of Dnmt3a immunoreactivity in the SCN (B). There was no 648 
effect of E2P4 on Dnmt3a immunoreactive cells in the Arc (C, D). There was no 649 
significant effect of E2P4 on Dnmt3b immunoreactive cells in the ependymal layer 650 
along the 3rdV (E, F). White lines denote the boundary of the SCN (B) and Arcuate 651 
(D). The white arrows indicate immunoreactive Dnmt3a/b cells. Abbreviations: 3rd 652 
ventricle (3rdV), Arcuate (Arc), oestrous (EST), Median eminence (ME), 653 
proestrous (PRO) and Suprachiasmatic nucleus (SCN). Asterisks indicate statistical 654 
significance by * P<0.05. Numbers in the bar graph denote sample size. 655 
 656 
Figure 3 – Ovarian steroid regulation of de novo DNA methyltransferase immunoreactive 657 
intensity in the female hamster hypothalamus. Dnmt3a cell intensity in the SCN 658 
(A) and Arc (B) was not significantly different between ovariectomized females 659 
treated with oil or E2P4. Ovarian steroids were found to significantly increase 660 
Dnmt3b signal intensity in the SCN (C), but there was no significant effect on 661 
immunoreactivity in the 3rdV (D). Asterisks indicate statistical significance by * 662 
P<0.05. Numbers in the bar graph denote sample size. 663 
 664 
Figure 4 – Diethylstilbestrol and Dihydrotestosterone effects on neuropeptide and DNA 665 
methyltransferase expression. Using mHypoE N36/1 (an immortalized 666 
hypothalamic neuronal cell line) neurons were treated with the highly potent 667 
estrogen agonist diethylstilbestrol (DES) (A, B). DES caused decreases in 668 
vasoactive intestinal polypeptide (Vip) and kisspeptin (Kiss1) expression (A) and 669 
upregulated Dnmt3b expression (B). There was no significant effect on vasopressin 670 
(Avp), Dnmt1 or Dnmt3a. Cells treated with DHT did not show significant 671 
variation in Dnmt1, Dnmt3a or Dnmt3b expression (C). Asterisks indicate 672 
statistical significance by * P<0.05. Numbers in the bar graph denote sample size. 673 
 674 
Figure 5 - In vitro analyses of DNA methylation on neuropeptides and circadian clock gene 675 
expression. Using mHypoE N36/1 neurons were treated with either the 676 
hypermethylation compound 3-aminobenzimide (3AB) or the DNMT inhibitor 677 
zebularine (ZEB). 3AB inhibited Vip (A) expression and Bmal1 (B) mRNA levels, 678 
but not vaopresson (Avp), kisspeptin (Kiss1), Clock (Clock) or period1 (Per1) 679 
expression. DNMT inhibition via ZEB application did not significantly affect Vip, 680 
Avp or Kiss1 expression (C). *P<0.05 vs. control. Numbers in the bar graph denote 681 
sample size. 682 
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